![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2009, European Molecular Biology Organization Stable kinetochore–microtubule interactions depend on the Ska complex and its new component Ska3/C13Orf3 1Department of Cell Biology, Max Planck Institute of Biochemistry, Martinsried, Germany 2Department of Structural Cell Biology, Max Planck Institute of Biochemistry, Martinsried, Germany 3Biozentrum, University of Basel, Basel, Switzerland aDepartment of Cell Biology, Max Planck Institute of Biochemistry, Am Klopferspitz 18, Martinsried 82152, Germany. Tel.: +49 89 8578 3100/3110; Fax: +49 89 8578 3102; E-mail: erich.nigg/at/unibas.ch *These authors contributed equally to this work Received November 6, 2008; Accepted March 20, 2009. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits distribution, and reproduction in any medium, provided the original author and source are credited. This license does not permit commercial exploitation or the creation of derivative works without specific permission. This article has been cited by other articles in PMC.Abstract Ska1 and Ska2 form a complex at the kinetochore–microtubule (KT–MT) interface and are required for timely progression from metaphase to anaphase. Here, we use mass spectrometry to search for additional components of the Ska complex. We identify C13Orf3 (now termed Ska3) as a novel member of this complex and map the interaction domains among the three known components. Ska3 displays similar characteristics as Ska1 and Ska2: it localizes to the spindle and KT throughout mitosis and its depletion markedly delays anaphase transition. Interestingly, a more complete removal of the Ska complex by concomitant depletion of Ska1 and Ska3 results in a chromosome congression failure followed by cell death. This severe phenotype reflects a destabilization of KT–MT interactions, as demonstrated by reduced cold stability of KT fibres. Yet, the depletion of the Ska complex only marginally impairs KT localization of the KMN network responsible for MT attachment. We propose that the Ska complex functionally complements the KMN, providing an additional layer of stability to KT–MT attachment and possibly signalling completion of attachment to the spindle checkpoint. Keywords: chromosome congression, kinetochore, microtubule-attachment, mitosis Introduction The mitotic spindle, formed at prophase by microtubules (MTs) originating from two spindle poles, generates the forces required for both chromosome congression to a metaphase plate, and the subsequent sister chromatid separation during anaphase. Essential to its function is the spindles' ability to attach to kinetochores (KTs), proteinaceous structures that assemble at the centromere of each sister chromatid (Cleveland et al, 2003; Maiato et al, 2004). Erroneous KT–MT attachment, with either both sister KTs attached to the same pole (syntelic attachment), or both poles attached to the same KT (merotelic attachment), can result in inaccurate segregation of the sister chromatids and subsequent aneuploidy (Pinsky and Biggins, 2005). To prevent aneuploidy, the cell generates a ‘wait-anaphase' signal known as the spindle assembly checkpoint (SAC) that inhibits anaphase onset until all KTs achieve biorientation, and tension is established between sister KTs (Musacchio and Salmon, 2007). Electron microscopy has revealed KT as a trilaminar structure: the inner KT, situated most proximal to the centromeric chromatin, the outer KT that provides the binding surface for spindle MTs, and a central linker region (Cheeseman and Desai, 2008). In addition, unattached KTs also show a fibrous corona, a dense array of fibres extending from the outer KT plate (McEwen et al, 1998). Binding of MTs to KTs is highly dynamic, and multiple protein complexes at the KT have been implicated in the process (Cheeseman and Desai, 2008). Of particular importance is the so-called KMN network (named after its key components KNL-1, Mis12 and Ndc80) that comprises three functionally linked complexes (Cheeseman et al, 2004, 2006; Obuse et al, 2004; Kline et al, 2006; Kiyomitsu et al, 2007; Ciferri et al, 2008). Individually, both Ndc80 and KNL-1 bind weakly to MTs, but the interaction of the Ndc80 complex is enhanced synergistically in the presence of the other KMN complex proteins (Cheeseman et al, 2006). Removal of any of the components of the KMN network disrupts both the structure of the outer KT plate and its ability to bind to MTs (DeLuca et al, 2005; Kline et al, 2006). Although the KMN is thought to provide the core binding sites for MTs at the KT, several other protein complexes also function at this critical interphase. These include the minus-end directed motor protein complex dynein/dynactin and proteins involved in its KT recruitment such as the RZZ complex (Karess, 2005; Yang et al, 2007), Spindly (Griffis et al, 2007; Yamamoto et al, 2008) and NudE and NudEL (Stehman et al, 2007). Moreover, the plus-end directed motor protein Cenp-E and its binding partner BubR1 are required for the maintenance of the KT–MT interaction (Lampson and Kapoor, 2005; Elowe et al, 2007; Matsumura et al, 2007). Finally, MT plus-end binding proteins (+Tips) such as EB1, Clip170 and Clasp (Maiato et al, 2004), and MT-bundling proteins like RanGAP1 (Joseph et al, 2004) have also been implicated in KT–MT binding and stabilization. Recently, we described the novel spindle KT-associated (Ska) complex, of which we identified two members, Ska1 and Ska2 (Hanisch et al, 2006). Ska1 was originally found in a proteomic survey of the human mitotic spindle (Sauer et al, 2005), whereas Ska2 was identified as a Ska1 binding partner in a yeast two-hybrid screen (Hanisch et al, 2006). In accordance with its identification as a spindle component, Ska1 was concentrated at the outer KT in a MT-dependent manner during prometaphase, where it remained until anaphase. Moreover, this localization was lost upon disruption of the outer KT plate by depletion of the Ndc80 component Hec1 (Hanisch et al, 2006). Interestingly, siRNA-mediated depletion of either Ska1 or Ska2 induced a prolonged metaphase arrest that could be overridden by the co-depletion of the SAC component Mad2 (Hanisch et al, 2006). Eventually, however, cells overcame the metaphase arrest, progressed through a normal anaphase and exited mitosis. Here, we describe a third member of the Ska complex, C13Orf3 (now termed Ska3), which we identified as a novel binding partner of Ska2 by mass spectrometry. Biochemical and immunocytochemical data confirm that Ska3 represents a bona fide member of the Ska complex, and its depletion induces a metaphase delay similar to that described for Ska1 and Ska2. Intriguingly, we show that a more stringent depletion of the entire Ska complex results in a severe chromosome congression defect that leads to cell death. In accordance with this phenotype, KT–MT attachment was severely impaired in Ska-depleted cells, although, remarkably, the KMN network was barely affected. Thus, we propose that the Ska complex is an essential component of the KT–MT interface, functioning in cooperation to the KMN network and possibly signalling the completion of successful attachment. Results and discussion Identification of C13Orf3 as a new component of the Ska complex To search for binding partners of the Ska complex (Hanisch et al, 2006), HeLa S3 cells were synchronized in mitosis and Ska2 was immunoprecipitated. Analysis of the immunoprecipitates by mass spectrometry (Figure 1A
Ska3 has a predicted molecular weight of 45 kDa but, as shown below, migrates at about 55 kDa (Figure 2B
The localization of Myc-tagged Ska3 in HeLa S3 cells was analyzed by indirect immunofluoresence microscopy (Figure 1C Next, we raised a rabbit polyclonal antibody against Ska3. When used for immunofluorescence microscopy, the anti-Ska3 serum produced a specific spindle and KT staining (Supplementary Figure 4A), indistinguishable from that seen with overexpressed Myc-tagged Ska3. By western blotting, the anti-Ska3 antibody detected a protein at a molecular weight of approximately 55 kDa in asynchronously growing cells (Supplementary Figure 4B). In addition, a band of even lower electrophoretic mobility was seen in mitotically arrested cells, suggesting that Ska3 is modified during mitosis (Figure 3A
To confirm the ability of Ska proteins to directly interact with each other, the three Ska components were expressed in Escherichia coli and used for in vitro reconstitution of a ternary complex (Figure 2A–D To determine whether a similarly large Ska complex could be identified in mitotic cells, lysates from nocodazole-arrested HeLa S3 cells were subjected to gel filtration and probed by western blotting for Ska components. As shown in Figure 2E Ska3 is required for Ska complex stability and function Earlier it has been shown that siRNA-mediated depletion of either Ska1 or Ska2 resulted in an increased mitotic index (Hanisch et al, 2006; Rines et al, 2008). Furthermore, the two proteins were found to influence each other's stability and localization (Hanisch et al, 2006). To determine whether Ska3 is also critical for the stability of the entire Ska complex, we examined the effect of Ska3 depletion on Ska1 and Ska2 in HeLa S3 cells. When compared with cells transfected with the control Gl2 oligonucleotide, the Ska3-specific siRNA oligonucleotide effectively depleted the protein, as shown by both western blotting (Figure 3A and B As mentioned above, Ska3 was clearly modified in mitosis, resulting in its reduced electrophoretic mobility. Analysis by mass spectrometry revealed that Ska3 can be phosphorylated on at least 18 different Ser/Thr residues and on at least one Tyr residue (Supplementary Figure 2A and B) (Brill et al, 2004; Rush et al, 2005; Nousiainen et al, 2006; Daub et al, 2008; Dephoure et al, 2008; Sui et al, 2008; Malik et al, in preparation; Santamaria et al, unpublished result). We, therefore, asked whether the upshift observed in western blots performed on mitotic lysates was due to an M-phase specific phosphorylation on Ska3. Treatment of lysates from mitotically arrested cells with λ phosphatase resulted in the complete loss of the slower migrating band and a concomitant increase in the faster migrating form, indicating that the observed retardation in electrophoretic mobility was indeed dependent on phosphorylation (Supplementary Figure 4C). Interestingly, exposure to calf intestinal phosphatase (CIP) resulted in an intermediate band, suggesting that different phosphorylation events on Ska3 give rise to distinct upshifts. Furthermore, when samples were collected at different times after release from a nocodazole block and examined by western blotting, we observed a step-wise increase in Ska3 mobility concomitant with securin degredation, suggesting that Ska3 is progressively dephosphorylated as cells exit mitosis (Supplementary Figure 4D). The M-phase specificity of Ska3 phosphorylation was further confirmed by demonstrating that Ska3 exists solely in its upshifted (phosphorylated) state when cells are blocked at the metaphase-to-anaphase transition by the addition of the proteosome inhibitor MG132 (Supplementary Figure 4D). The upshifted form of Ska3 was also detected in mitotic cells collected by shake-off 10 h after thymidine release (data not shown), indicating that it is not an artefact caused by prolonged exposure to an anti-mitotic drug. Taken together, these results clearly show that Ska3 is highly phosphorylated during M-phase and then dephosphorylated after SAC inactivation and anaphase onset. In future, it will be interesting to elucidate the role of Ska3 phosphorylation during mitotic progression. One possibility would be that phosphorylation regulates Ska complex formation, but given that interactions among the three Ska proteins can readily be detected amongst recombinant proteins purified from E. coli (Figure 2 Extensive depletion of the Ska complex causes a chromosome congression defect To explore the function of Ska3, the consequences of depleting individual Ska proteins were examined by live cell imaging performed on HeLa S3 cells stably expressing Histone H2B-GFP. When compared with Gl2-treated control cells, depletion of Ska3, Ska2 or Ska1 resulted in a striking delay between metaphase plate formation and anaphase onset (Figure 4A
The fact that knock-down of individual Ska proteins delays cells in a metaphase-like state but does not ultimately prevent the completion of mitosis could be interpreted to imply that this complex is not strictly required for mitotic progression. Alternatively, however, the transient nature of the arrest may reflect incomplete depletion of the Ska complex. To explore this latter possibility, we pooled siRNA oligonucleotides targeting two Ska components simultaneously, in the hope that this would achieve a more complete depletion of the Ska complex than any ‘single' knock-down. Quantitative analysis of western blotting revealed that double-siRNA treatment resulted in a more extensive depletion of Ska complex components than single-siRNA treatment, particularly when depletion efficiency was assessed at relatively early time points (Supplementary Figure 5A and B). As shown by time-lapse microscopy, the single depletion of Ska components produced a marked metaphase delay (Figure 4B and E We presume that some cells survived the double-siRNA treatment because they suffered a less complete depletion of the Ska complex. These latter cells eventually reached a stage resembling metaphase, but they required substantially more time (105±35 min for Ska1/Ska3 double depletion) than either cells depleted of Ska3 alone (24±7 min) or Gl2 controls (19±3 min). The exact same Ska-depleted cells then also required much more time to progress to anaphase than Gl2 controls, but differences between singly and doubly siRNA-treated cells were less pronounced (89±36 min for Ska3 single depletion, compared with 124±33 min for Ska1/Ska3 double depletion) (see Figure 4C–E Removal of the Ska complex compromises MT–KT attachment The inability of chromosomes to form a metaphase plate after extensive removal of the Ska complex indicated a possible role of this complex in MT capture and/or maintenance of KT attachment. To explore this possibility, we first confirmed that Ska3 recruitment to KTs was dependent on MTs (Supplementary Figure 6A) and required the presence of the Ndc80 complex (Supplementary Figure 6B), similar to results obtained earlier for Ska1 and Ska2 (Hanisch et al, 2006). Next, we adapted a recently described assay (Toso et al, 2009) to examine the extent of MT interactions with KTs. Specifically, the α-Tubulin signal of MTs was measured and normalized to the CREST signal at KTs (see Materials and methods). As illustrated in Figure 5A
In a final series of experiments, we asked whether the extensive removal of the Ska complex affected the localization of KMN components required for KT–MT stabilization (DeLuca et al, 2002; Cheeseman et al, 2006; Kline et al, 2006). Co-depletion of Ska1 and Ska3 did not detectably reduce the overall cellular levels of either Hec1 or Blinkin, the human homologue of KNL-1 (Kiyomitsu et al, 2007) (Supplementary Figure 7A), nor did they produce a major effect on the localization of these proteins (Figure 5G and H These results argue that the absence of the Ska complex does not significantly disrupt the core KT structure. However, the fact that k-fibre stability is lost upon Ska depletion despite the presence of the KMN network indicates that the Ska complex has an important function in stabilizing KT–MT attachments (Figure 6
In summary, we describe the novel phosphoprotein Ska3 (formerly C13Orf3). We show that this protein is a core component of the Ska complex, required for both complex stability and function. Furthermore, through double-depletion siRNA experiments resulting in the near-complete removal of the entire Ska complex, we have been able to describe an essential role for the Ska complex in MT–KT attachment and chromosome congression. Thus, the Ska complex has a more central function in mitotic progression than surmised earlier. We propose that the Ska complex cooperates with the KMN to create the dynamic MT–KT interface that is required for MT attachment, chromosome congression and subsequent segregation. In particular, we speculate that the Ska complex may function as a clamp to stabilize the MT–KT attachments established through the KMN, perhaps providing an analogous function to the Dash–Duo–Dam complex of budding yeast (Cheeseman et al, 2001; Westermann et al, 2007). Additionally, it would be premature to exclude an additional signalling function in the silencing of the SAC (Hanisch et al, 2006). Perhaps, the functions provided by the Ska complex are particularly critical in organisms in which multiple MTs attach to a single KT. This would readily explain the apparent absence of genes coding for Ska proteins from the published yeast genomes. Materials and methods Cloning procedures For cloning of Ska3 (C13Orf3), a cDNA clone (IRATp970D0864D) was obtained from the ‘Deutsches Ressourzentrum für Genomforschung'. This cDNA was cloned in-frame into a pCDNA3.1 vector (Invitrogen, Carlsbad, CA) encoding an N-terminal 3xMyc tag. Protein purification and antibody production Antibodies against Ska3 were generated by immunization of rabbits with four injections of 250 μg of N-terminally His6-tagged full-length protein produced in E. coli (Charles River Laboratories, Romans, France). Anti-Ska3 antibodies were affinity purified by applying 1.5 ml immune serum onto nitrocellulose filters containing 400 μg of the antigen used for immunization. The filters were extensively washed with PBST, and anti-Ska3 antibodies were subsequently eluted from the filters with glycine buffer (100 mM pH 2.8) and dialyzed against PBST. Cell culture and synchronization HeLa S3, HeLa S3 H2B-GFP and HEK293T cells were cultured in a 5% CO2 atmosphere in Dulbecco's modified Eagle's medium (Invitrogen), supplemented with 10% heat-inactivated fetal calf serum (FCS) and penicillin streptomycin (100 IU/ml and 100 μg/ml, respectively). To arrest cells at prometaphase, they were treated with 50 ng/ml nocodazole (Sigma, St Louis, MO) for 16 h, and mitotic cells were collected by mechanical shake-off, washed twice with PBS, and released into normal growth medium. Samples were taken either from arrested cells or after release for stated time intervals. Alternatively, cells were treated with 45 μg/ml monastrol (Sigma) for 16 h. Transient transfections and siRNA Plasmid transfections were performed using TransIT®-LT1 reagent (Mirus Bio Corporation, Madison, WI) according to the manufacturer's instructions. siRNA duplexes were transfected using Oligofectamine (Invitrogen) as described elsewhere (Elbashir et al, 2001). The sequence of the siRNA duplex for targeting Ska3 was: 5′-AGACAAACAUGAACAUUAA-3′ (Qiagen, Hilden, Germany). Ska1 and Ska2 were depleted using established siRNAs targeting published sequences (Hanisch et al, 2006), and Hec1 was depleted using established siRNA targeting published sequence (Martin-Lluesma et al, 2002). As control, a duplex (Gl2) targeting luciferase was used (Elbashir et al, 2001). In experiments comparing single- and double-siRNA treatments, the total concentration of oligonucleotides administered to the cells was kept constant by the addition of Gl2 where applicable. Cell extracts, immunoprecipitation, western blotting analysis and gel filtration Lysates were prepared using Hepes lysis buffer (50 mM Hepes pH 7.4, 150 mM NaCl, 0.5% Triton X-100) containing 30 μg/ml RNAse A, 30 μg/ml DNase, 1 μM Okadaic acid, phosphatase inhibitors and complete mini protease inhibitor tablets (1/10 ml) (Roche Diagnostics, Indianapolis, IN). Protein concentrations were determined using the Dc protein assay (Bio-Rad Laboratories, Hercules, CA). Lysates were incubated for 2–4 h at 4°C with 9E10 anti-Myc antibodies (1:10, 9E10 tissue culture supernatant). In each case, 1 μg of antibody was coupled to 1 μl sepharose-A beads (20 μl beads in total) (Pierce, Rockford, IL). After protein capture, beads were washed 4 × with Hepes lysis buffer and resuspended in gel sample buffer and proteins were analysed by SDS–PAGE and immunoblotting. Membranes were probed with the following antibodies: affinity-purified rabbit anti-Ska1 and anti-Ska2 and anti-Ska3 (1 μg/ml), mouse mAb anti-Securin (1:1000, Abcam, Cambridge, UK), mouse mAb anti-Hec1 (1:1000, Abcam), mouse mAb anti-Blinkin (1:200, gift from M Yanaguida), and mouse mAb anti-α-Tubulin (Sigma). Gel filtration was carried out on mitotic HeLa S3 cells collected by shake-off after synchronization by a sequential thymidine/nocodazole block release protocol, and lysed in NP40-lysis buffer (PBS with 0.5% NP40, complete mini protease inhibitor tablets (1/10 ml) (Roche), and Phosphatase Inhibitors Cocktails 1 and 2 (Sigma)). Before gel filtration, lysates were cleared by sequential centrifugation (4°C) at 16 000 and 200 000 g. Protein extract (6 mg) was then loaded on a Superose 6 10/300 GL column (GE Healthcare, Piscataway, NJ), and isocratic elution was performed at 0.4 ml/min at 4°C with PBS, collecting fractions every 0.65 ml. The protein content of each fraction was precipitated by addition of TCA (13%) followed by centrifugation at 4°C. Protein pellets were washed twice with acetone, dried and resuspended in 60 μl of Laemmli sample buffer. Fractions (10 μl) were loaded on SDS–PAGE and analysed by western blotting. Ska2 immunoprecipitation and mass spectrometry analysis For Ska2 immunoprecipitation, mitotic HeLa S3 cells were harvested by shake-off after 16 h nocodazole treatment and release for 40 min. Lysates were prepared using Hepes lysis buffer (see above) and were pre-cleared for 6 h at 4°C with rabbit IgG and Ska2 was subsequently immunoprecipitated overnight with anti-Ska2 antibodies. In each case, 40 μg of antibody was coupled to 40 μl sepharose-A beads (Pierce). After protein capture, beads were washed 4 × with Hepes lysis buffer, resuspended in gel sample loading buffer and resolved by NuPAGE gel (Invitrogen). The gel was processed for analysis by mass spectrometry. This involved in-gel digestion of Coomassie-stained protein bands by trypsin (Promega, sequencing grade) (Shevchenko et al, 1996) and desalting using home-made miniaturized reversed-phase columns (Rappsilber et al, 2003). Peptide mixtures were chromatographically separated with a nanoACQUITY ultra performance liquid chromatography system (Waters, Hertfordshire, UK) connected to a hybrid linear ion trap/orbitrap tandem mass spectrometer (Thermo Electron, Waltham, MA). Peptides dissolved in 0.5% formic acid were loaded to a 14 cm pulled fused silica capillary with an inner diameter of 75 μm and a tip of 8 μm (New Objective, Woburn, MA) packed with reversed-phase ReproSil-Pur C18-AQ 3 μm resin (Dr Maisch GmbH, Ammerbuch-Entringen, Germany). Peptides were separated and eluted by a stepwise 60-min gradient of 0–100% between buffer A (0.2% formic acid in water) and buffer B (0.2% formic acid in acetonitrile). The mass spectrometer was operated in data-dependent MS/MS mode. Survey full scan MS spectra (from m/z 300–2000) were acquired in the FT-Orbitrap with a resolution of 60 000 at m/z 400. A maximum of five peptides were sequentially isolated for fragmentation in the linear ion trap using collision-induced dissociation. MASCOT (version 2.2.0, Matrix Science, London, UK) was used for protein identifications from the human International Protein Index database. For searches, the precursor mass tolerance was set to ±5 ppm, whereas an accuracy of ±0.6 Da was used for MS/MS spectra. Carbamidomethylation was set as fixed modification, whereas oxidation, deamidation (NQ) and phosphorylation (STY) were considered as variable modifications. In vitro characterization of Ska complex Full-length and truncated versions of Ska1, Ska2 and Ska3 as N-terminal His- or GST-tagged proteins were cloned into pEC series of vectors (Ligation Independent Cloning modified from pET-28a vector) designed in house. C-terminally His-tagged full-length Ska3 cloned into a pET-28 vector, and untagged Ska2 was cloned into a pET-11 vector. Proteins were expressed in E. coli strain BL21Gold (pLysS) with an overnight induction at 18°C (with 0.2 mM IPTG). Cells were lysed in a buffer containing 20 mM Tris pH 7.5, 500 mM NaCl and 1 mM DTT. Full-length and truncated protein complexes were purified by affinity chromatography with glutathione sepharose 4B beads (GE Healthcare). The affinity tags were cleaved using TEV protease after extensive washing, whereas the proteins were still bound to the beads, followed by anion exchange with a final size exclusion chromatography (Superdex 200, GE Healthcare). The pure reconstituted complex was analysed on a 15% SDS–PAGE gel staining with Coomassie. For the GST-pulldown experiment, GST–Ska2 (full length) and His–Ska3 (full length) were co-expressed in conditions as mentioned above. Phosphatase treatment HeLa S3 cells were kept asynchronously growing or were arrested with 150 ng/ml nocodazole for 16 h. The corresponding cell lysates were treated with either CIP (New England Biolabs, Ipswich, MA) or λ Phosphatase (Roche, Indianapolis, IN) or left untreated for 2 h at 30°C. The phosphatase reaction was stopped by addition of sample buffer followed by boiling. Equal protein amounts were loaded and separated by SDS–PAGE followed by western blotting analysis. Immunofluorescence microscopy Cells were grown on coverslips and fixed and permeabilized as described earlier (Sillje et al, 2006). Primary antibodies used in this study were rabbit anti-Ska1 and rabbit anti-Ska2 (Hanisch et al, 2006), mouse mAb anti-Myc (1:10, 9E10 tissue culture supernatant), human CREST autoimmune serum (1:2000, Immunovision, Springdale, AR), mouse mAb anti-Hec1 (1:1000, Abcam), mouse mAb anti-Blinkin (1:1000, gift from M. Yanaguida). Primary antibodies were detected with Cy2-, Cy3- and Cy5-conjugated donkey anti-mouse, anti-rabbit or anti-human IgGs (1:1000, Dianavo, Hamburg, Germany). DNA was stained with DAPI (2 μg/ml). Immunofluorescence microscopy was performed with Zeiss Axio Observer Z1 microscope (Visitron Systems GmbH, Puccheim, Germany), equipped with plan-apochromat 63 × objective, and a CoolSNAP-HQ2 CCD camera. Where applicable, z-axis optical sections were recorded every 0.5 μm, images of a single focal plane were processed with a deconvolution algorithm and optical sections were projected into one picture using Metamorph 7.1 software (Molecular Devices, Sunnyvale, CA). Images were cropped in Adobe Photoshop 6.0 and then sized and placed in figures using Adobe Illustrator 10 (Adobe Systems, San Jose, CA). Image quantification Immunofluorescent and western blotting images were quantified using ImageJ software (http://rsb.info.nih.gov/ij/). For immunofluorescence, images used for quantification were taken with identical exposure times within each experiment, acquired from z-axis optical sections every 0.3 μm and compressed to a single plane without deconvolution. Quantification of KT intensities was preformed using a method adapted from that described earlier (Elowe et al, 2007). Essentially, a circular region with fixed diameter was centred on each KT, and the average pixel intensity was measured. CREST intensity was measured in the same region and used for normalization after subtraction of background intensity measured within a cytoplasmic, non-specific region of the cell as described earlier (Toso et al, 2009). To measure the extent of MT attachment at the KT, we adapted the method described recently (Toso et al, 2009). Images were acquired and processed as above, and the intensity of the α-Tubulin signal at the KT measured and normalized against the KT CREST signal, after subtraction of cytoplasmic background intensity for each individual cell. Statistical significances of quantification experiments were verified by Student's t-test. For quantification of western signal, a set area around the band of interest was selected, the average pixel intensity measured, and the average background signal from an area of identical size at a non-specific region of the membrane was subtracted. The results are presented normalized to the signal for α-Tubulin. Time-lapse microscopy For time-lapse microscopy, a HeLa S3 cell line stably expressing Histone H2B-GFP was used (Sillje et al, 2006). Cells were treated with siRNAs for 36 h before image acquisition. The culture plate (Ibidi, Martinsried, Germany) was placed onto a sample stage within an incubator chamber (EMBLEM, Heidelberg, Germany) maintained at a temperature of 37°C, humidity 60%, in an atmosphere of 5% CO2. Imaging was performed using a Zeiss Axio Observer Z1 microscope equipped with a Plan Neofluar 20 × objective. Metamorph 7.1 software (Molecular Devices) was used to collect and process data. Images were captured using 10 ms exposure times every 3-min interval for 16 h. Supplementary Movie 1 Click here to view.(213K, mov) Supplementary Movie 2 Click here to view.(146K, mov) Supplementary Movie 3 Click here to view.(105K, mov) Supplementary Movie 4 Click here to view.(75K, mov) Supplementary Movie 5 Click here to view.(348K, mov) Supplementary Movie 6 Click here to view.(146K, mov) Supplementary Movie 7 Click here to view.(552K, mov) Supplementary Information Click here to view.(1.1M, pdf) Acknowledgments We thank Mitsuhiro Yanagida (Kyoto University) for the Blinkin antibody. We are thankful to Anja Wehner for excellent technical assistance, Luca Fava for help with gel filtration, Rainer Malik for bioinformatic support and Roman Körner for mass spectrometry guidance. We gratefully acknowledge Stefan Hümmer, Lily Wang and Sabine Elowe for helpful discussions. This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft (SFB 646), and ENFIN, a Network of Excellence funded by the European Commission within its FP6 Programme (contract number LSHG-CT-2005-518254). AS is supported by a postdoctoral fellowship from the Spanish Education and Science Ministry. BW is partially supported by the Chinese Academy of Sciences. Footnotes The authors declare that they have no conflict of interest. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Cell. 2003 Feb 21; 112(4):407-21.
[Cell. 2003]J Cell Sci. 2004 Nov 1; 117(Pt 23):5461-77.
[J Cell Sci. 2004]Trends Cell Biol. 2005 Sep; 15(9):486-93.
[Trends Cell Biol. 2005]Nat Rev Mol Cell Biol. 2007 May; 8(5):379-93.
[Nat Rev Mol Cell Biol. 2007]Nat Rev Mol Cell Biol. 2008 Jan; 9(1):33-46.
[Nat Rev Mol Cell Biol. 2008]Chromosoma. 1998 Dec; 107(6-7):366-75.
[Chromosoma. 1998]Genes Dev. 2004 Sep 15; 18(18):2255-68.
[Genes Dev. 2004]Cell. 2006 Dec 1; 127(5):983-97.
[Cell. 2006]Nat Cell Biol. 2004 Nov; 6(11):1135-41.
[Nat Cell Biol. 2004]Trends Cell Biol. 2005 Jul; 15(7):386-92.
[Trends Cell Biol. 2005]Curr Biol. 2007 Jun 5; 17(11):973-80.
[Curr Biol. 2007]J Cell Biol. 2007 Jun 18; 177(6):1005-15.
[J Cell Biol. 2007]J Cell Biol. 2008 Oct 20; 183(2):187-94.
[J Cell Biol. 2008]J Cell Biol. 2007 Aug 13; 178(4):583-94.
[J Cell Biol. 2007]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]Mol Cell Proteomics. 2005 Jan; 4(1):35-43.
[Mol Cell Proteomics. 2005]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]Nucleic Acids Res. 2008 Jul 1; 36(Web Server issue):W197-201.
[Nucleic Acids Res. 2008]J Cell Biol. 1999 Apr 19; 145(2):237-54.
[J Cell Biol. 1999]J Biol Chem. 2001 Jul 13; 276(28):26559-67.
[J Biol Chem. 2001]Proc Natl Acad Sci U S A. 2007 Jan 23; 104(4):1201-6.
[Proc Natl Acad Sci U S A. 2007]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]Genome Biol. 2008; 9(2):R44.
[Genome Biol. 2008]Anal Chem. 2004 May 15; 76(10):2763-72.
[Anal Chem. 2004]Nat Biotechnol. 2005 Jan; 23(1):94-101.
[Nat Biotechnol. 2005]Proc Natl Acad Sci U S A. 2006 Apr 4; 103(14):5391-6.
[Proc Natl Acad Sci U S A. 2006]Mol Cell. 2008 Aug 8; 31(3):438-48.
[Mol Cell. 2008]Proc Natl Acad Sci U S A. 2008 Aug 5; 105(31):10762-7.
[Proc Natl Acad Sci U S A. 2008]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]J Cell Biol. 2009 Feb 9; 184(3):365-72.
[J Cell Biol. 2009]J Cell Biol. 2002 Nov 25; 159(4):549-55.
[J Cell Biol. 2002]Science. 2002 Sep 27; 297(5590):2267-70.
[Science. 2002]Chromosoma. 1981; 84(1):145-58.
[Chromosoma. 1981]J Cell Biol. 2002 Nov 25; 159(4):549-55.
[J Cell Biol. 2002]Cell. 2006 Dec 1; 127(5):983-97.
[Cell. 2006]J Cell Biol. 2006 Apr 10; 173(1):9-17.
[J Cell Biol. 2006]Dev Cell. 2007 Nov; 13(5):663-76.
[Dev Cell. 2007]Nat Cell Biol. 2005 Jan; 7(1):93-8.
[Nat Cell Biol. 2005]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]Mol Biol Cell. 2005 Feb; 16(2):519-31.
[Mol Biol Cell. 2005]J Cell Biol. 2001 Jan 8; 152(1):197-212.
[J Cell Biol. 2001]Annu Rev Biochem. 2007; 76():563-91.
[Annu Rev Biochem. 2007]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]Nature. 2001 May 24; 411(6836):494-8.
[Nature. 2001]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]Science. 2002 Sep 27; 297(5590):2267-70.
[Science. 2002]Anal Chem. 1996 Mar 1; 68(5):850-8.
[Anal Chem. 1996]Anal Chem. 2003 Feb 1; 75(3):663-70.
[Anal Chem. 2003]Curr Biol. 2006 Apr 18; 16(8):731-42.
[Curr Biol. 2006]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]Genes Dev. 2007 Sep 1; 21(17):2205-19.
[Genes Dev. 2007]J Cell Biol. 2009 Feb 9; 184(3):365-72.
[J Cell Biol. 2009]Curr Biol. 2006 Apr 18; 16(8):731-42.
[Curr Biol. 2006]EMBO J. 2006 Nov 29; 25(23):5504-15.
[EMBO J. 2006]